Date
31 August 2023
Curbing AMR through sustainable antibiotic manufacturing
European Pharmaceutical Review covers the launch of the Foundation's report on AMR and responsible manufacturing, putting it into the context of global shortages of antibiotics.
Direct links
The article highlights the lack of global regulations on wastewater discharges from antibiotic manufacturing sites, noting the report includes some examples of companies proactively trying to address the issue.
Marijn Verhoef, the Foundation's Director of Operations and Research is quoted: “By investing in responsible manufacturing, companies can help curb rising drug resistance while positioning themselves favourably in the market.”